chr11-5885137-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005165.2(OR52E4):āc.845T>Cā(p.Val282Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000315 in 1,613,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005165.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR52E4 | NM_001005165.2 | c.845T>C | p.Val282Ala | missense_variant | 2/2 | ENST00000641726.1 | |
LOC112268071 | XR_002957231.2 | n.365-3708A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR52E4 | ENST00000641726.1 | c.845T>C | p.Val282Ala | missense_variant | 2/2 | NM_001005165.2 | P1 | ||
TRIM5 | ENST00000412903.1 | c.-62+52264A>G | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152042Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000760 AC: 19AN: 250040Hom.: 0 AF XY: 0.0000739 AC XY: 10AN XY: 135230
GnomAD4 exome AF: 0.000337 AC: 493AN: 1461268Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 254AN XY: 726950
GnomAD4 genome AF: 0.000105 AC: 16AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74396
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 14, 2023 | The c.845T>C (p.V282A) alteration is located in exon 1 (coding exon 1) of the OR52E4 gene. This alteration results from a T to C substitution at nucleotide position 845, causing the valine (V) at amino acid position 282 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at